Journal: Journal of oral biosciences
Article Title: P2 purinergic receptor signaling and interleukin-1 synergistically induce interleukin-6 production in a human oral squamous carcinoma cell line.
doi: 10.1016/j.job.2021.01.004
Figure Lengend Snippet: Fig. 7. Effects of mitogen-activated protein kinase (MAPK) inhibitors on interleukin (IL)-6 production by HSC-2 cells stimulated with adenine nucleotides and IL-1a. (AeC) HSC-2 cells were stimulated with 100 mM ATP or ADP and 10 ng/ml IL-1a for 10 min. Whole cell lysates (2.5 mg protein in each lane) were analyzed using western blotting with anti- p38 and anti-p-p38 (A), anti-JNK and anti-p-JNK (B), and anti-ERK and anti-p-ERK (C) antibodies. Data shown are representative of three independent experiments. Bars show the mean ± standard deviation (SD) of three or four independent experiments. (DeF) Cells were preincubated for 30 min with the p38 inhibitor SB203580 (D), the JNK inhibitor SP600125 (E), or the ERK inhibitor PD98059 (F) at the indicated concentrations, then further stimulated with 100 mM ATP or ADP and 10 ng/ml IL-1a for 24 h. The concentrations of IL-6 in culture supernatants were measured using enzyme-linked immunosorbent assay (ELISA). **P < 0.01, *P < 0.05, significantly different from the control (0 mM inhibitor). Values in the graphs are expressed as the mean ± SD of a single experiment performed in triplicate.
Article Snippet: UDP, Evans blue, pyridoxalphosphate-6-azophenyl-20,40-disulfonic acid (PPADS), suramin, and anti-human IL-1a antibody were purchased from Abcam (Cambridge, UK).
Techniques: Western Blot, Standard Deviation, Enzyme-linked Immunosorbent Assay, Control